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Abstract 26 
 27 
Purpose of review: Trials of physical rehabilitation post critical illness have yet to 28 
deliver improved health related quality of life in critical illness survivors. Muscle 29 
mass and strength are lost rapidly in critical illness and a proportion of patients 30 
continues to do so resulting in increased mortality and functional disability. 31 
Addressing this issue is therefore fundamental for recovery from critical illness 32 
Recent findings: Altered mitochondrial function occurs in the critically ill and is likely 33 
to result in decreased Adenosine Tri-Phosphate (ATP) production. Muscle 34 
contraction is a process that requires ATP. The metabolic demands of exercise are 35 
poorly understood in the ICU setting. Recent research has highlighted that there is 36 
significant heterogeneity in energy requirements between critically ill individuals 37 
undertaking the same functional activities, such as sit-to-stand. Nutrition in the 38 
critically ill is currently thought of in terms of carbohydrates, fat and protein. It may 39 
be that we need to consider nutrition in a more contextual manner such as energy 40 
generation or management of protein homeostasis. 41 
Summary: Current nutritional support practices in critically ill patients do not lead to 42 
improvements in physical and functional outcomes, and it may be that alternative 43 
methods of delivery or substrates are needed. 44 
 45 
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Introduction 48 
Physical rehabilitation trials have yet to deliver increased functional capacity or 49 
improve health related quality of life in critical illness survivors1. All things being 50 
equal, muscle mass is directly related to muscle strength, and is therefore a major 51 
determinant of physical function. Regardless of the measurement method used, 52 
muscle mass and strength is lost rapidly in critical illness2, a process that continues 53 
post critical illness3. This is associated with increased mortality4 and functional 54 
disability3. Addressing this issue is therefore fundamental for recovery from critical 55 
illness. Muscle mass is maintained by protein homeostasis, a highly energy 56 
dependent process. Without sufficient energy generation, exercise interventions will 57 
not succeed in maintenance of protein homeostasis. 58 
 59 
The bioenergetics status of the critically ill patient  60 
Altered mitochondrial function occurs in sepsis and multi-organ failure5 that is likely 61 
to result in decreased Adenosine Tri-Phosphate (ATP) production.  The causality of 62 
this observed phenomena is unclear, altered mitochondrial function being either: a 63 
response to extra-cellular stimuli (e.g. inflammation), or a protective mechanism (to 64 
prevent utilization of biological stores). For the patient, the resulting phenotype is 65 
the same. Lack of ATP will hinder muscle protein synthesis (MPS), with acute muscle 66 
wasting leading to functional disability on discharge. Further lack of ATP may trigger 67 
proteolysis, accelerating loss of muscle mass6. Altered mitochondrial function may 68 
additionally affect muscle satellite cells7 altering regenerative capacity, which in turn 69 
would lead to altered muscle quality8 further impairing muscle function. 70 
ATP is generated by the linking of oxidation of substrate to phosphorylation of 71 
Adenosine Di-Phosphate, i.e. oxidative phosphorylation. ATP is additionally 72 
necessary for skeletal muscle contraction, leading to force generation i.e. exercise. 73 
Interestingly this is a bidirectional relationship: exercise training is able to increase 74 
the capacity for ATP supply and mitochondrial density9. Glycolysis produces pyruvate 75 
for the Citric Acid cycle and high-energy electrons for the electron transport chain. 76 
Fatty Acid Oxidation produces Nicotinamide adenine dinucleotide (NADH) and Flavin 77 
adenine dinucleotide (FADH2) and Acetyl-Coenzyme-A, which are used in the Citric 78 
Acid Cycle and the electron transport chain10. These are enzyme driven processes- in 79 
the setting of altered mitochondrial function, increasing substrate delivery is unlikely 80 
to alter substrate processing, and therefore unlikely to produce more ATP. 81 
 82 
Two processes common to critical illness may alter pre-intensive care unit (ICU) 83 
mitochondrial function and subsequent ATP generation- age and chronic disease 84 
states.  Aging muscle is associated with decreased mitochondrial efficiency, though 85 
there has been little control for sedentary behavior.  Immobilization does result in 86 
decreased mitochondrial efficiency. This may contribute to the altered mitochondrial 87 
function seen with chronic disease states either at rest or following a physiological 88 
stressor. This complex metabolic state is likely to be a result of metabolic adaptation, 89 
from decreased insulin sensitivity in diabetic patients to muscle fibre type shifts in 90 
those chronic diseases associated with sedentary behavior and immobilization. In 91 
summary, not only is energy production likely to be impaired in critical illness, 92 
patients are likely to enter critical illness with varying abilities to oxidise substrate 93 
and produce ATP. 94 
 95 
Skeletal muscle adaption to loading and energy requirements  96 
Myofibrils are the smallest structural unit of a muscle fibre and contain two main 97 
contractile filaments, actin (thin filaments) and myosin (thick filaments), which are 98 
responsible for contractile functioning and force production.  The interaction of 99 
these filaments induces muscle contraction - a process that requires ATP. Muscle 100 
fibres exhibit different contraction properties based on differences in energy 101 
hydrolysis and synthesis. The terms ‘slow’ or ‘fast’ twitch fibre typing is used to 102 
describe the speed of contraction, level of microvascular capillarisation, oxidative 103 
enzymes and metabolic means of generating energy production (aerobic or 104 
anaerobic) 11. The musculoskeletal system is a highly plastic and adaptive system 105 
responding quickly to changes in mechanical loading particularly due to immobility 106 
and sepsis12.  107 
 108 
It is recognized that other factors influence muscle force production including 109 
muscle fibre arrangement, tendon stiffness, and motor unit discharge rates and 110 
neurohormonal states. Where there is reduced mechanical loading and/or increased 111 
energy demands due to heightened states of physical stress -such as seen in critical 112 
illness - imbalance in muscle protein homeostasis can ensue14.  113 
Effect of pre-ICU health and post ICU recovery on skeletal muscle dysfunction  114 
As with mitochondrial function (detailed above) pre-ICU health factors such as age, 115 
comorbidities and frailty influence muscle mass on admission to the ICU and the 116 
potential recovery trajectory 13. Considerable patient heterogeneity results in 117 
differing responses between individuals post critical illness14, demonstrated in  118 
secondary analyses of ‘negative’ rehabilitation RCTs 15 16.  119 
The mechanistic changes for muscle dysfunction in critical illness continue to be 120 
elucidated . It is established that muscle wasting occurs early and rapidly with up to 121 
30% reduction in first 10 days12 14. Heightened muscle protein catabolism is evident 122 
in individuals with higher severity of illness 6 12. Additionally macrophagic infiltration, 123 
myonecrosis, preferential reduction of myosin and reduction in mitochondrial 124 
content have been demonstrated in the early phases of muscle degradation 6 12. 125 
Reduced motor nerve excitability with impairment in membrane excitability occurs, 126 
impacting muscle contraction 17.  Mechanisms of chronic muscle wasting and 127 
dysfunction six months post discharge are not just due to ongoing low muscle mass 128 
but also reduced satellite cells, angiogenesis, and increased intramuscular fat and 129 
connective tissue infiltration6, impacting on the ability of skeletal muscle to adapt 130 
and respond to changes in mechanical loading through exercise 6.  131 
 132 
How can we ‘load’ or train skeletal muscle – Exercise Principles 133 
The American College of Sports Medicine (ACSM) has defined resistance training as a 134 
form of physical activity that is designed to improve muscular fitness by exercising a 135 
muscle in isolation or a muscle group against external resistance 18. Training 136 
methods will vary depending on the purpose for resistance training – strength, 137 
endurance, or power 18. In order to maintain muscle mass or induce hypertrophy 138 
overloading of the muscle is required. This is dependent on intact structural, 139 
neurohormonal, cardiovascular and metabolic energy system, which can be 140 
compromised in critically ill. Consideration of frequency, load resistance, type of 141 
exercises and volume (number of repetitions and sets) are critical to designing an 142 
efficacious training program 18. To our knowledge there are no studies which have 143 
specifically examined resistance training on its own in the ICU setting – recent RCTs 144 
have incorporated resistance training as one facet within physical rehabilitation 19 20.   145 
 146 
Resistance training in the ICU setting and metabolic costs  147 
Resistance exercises can involve functional multi-joint strengthening exercises such 148 
as sit-to-stand, which are highly important to everyday activities of daily living. The 149 
ICU environment is fraught with complexities that impact on the ability of patients to 150 
engage in physical activity. The barriers to physical activity were recently highlighted 151 
in a systematic review and include patient, clinician and institutional level 152 
influences21. With introduction of guidelines and frameworks for optimizing pain, 153 
agitation and delirium management there has been a paradigm shift towards 154 
creating an animated ICU in which patient engagement can be optimized 22 23. There 155 
still remains challenges however in the initial ICU admission period where patients 156 
may be unable to volitionally participate in rehabilitation strategies. Given muscle 157 
loss occurs early and rapidly there is a need to consider ways in which ‘loading’ 158 
forces may be applied to maintain muscle mass integrity.  159 
The metabolic demands of exercise are poorly understood in the ICU setting. Recent 160 
research has highlighted that there is significant heterogeneity in energy 161 
requirements between critically ill individuals undertaking the same functional 162 
activities24. Energy requirements are higher in the critically ill compared to healthy 163 
individuals 24. A strong correlation exists between active energy expenditure 164 
measured using a physical activity device and the highest level of mobility 25. 165 
However the ability to detect low levels of activity is challenging when patients are 166 
relatively immobile compounded by potential inaccuracies in energy assessment 167 
with physical activity devices 26. Additionally metabolic demands are likely to differ 168 
for in bed versus out of bed activity – but have not yet been examined.  169 
The metabolic demand of resistance training has been examined in non-ICU settings. 170 
Eccentric muscle contraction (involving generation of muscle force during muscle 171 
lengthening) induces lower metabolic demands compared to concentric muscle 172 
contractions 27. Resistance training methodology is therefore as important as 173 
considerations of the potential adverse effects of overtraining. Response to training 174 
is variable and further research into individualizing interventions whilst considering 175 
metabolic reserve and baseline and exercise energy expenditure 176 
Future directions for the field include understanding the synergy and interaction 177 
between nutrition and exercise 28. Consideration of timing of nutrition may therefore 178 
be important not only prior /during resistance training but also in the post exercise 179 
period.  180 
 181 
Substrate delivery and energy generation-not the same thing 182 
In health, protein, fat and carbohydrate are all required for ATP synthesis.  In 183 
addition, co-factors, such as b-vitamins, and insulin are required for this process to 184 
occur.  In athletes, appropriate nutrition is essential to achieving and maintaining 185 
peak exercise performance and is prioritized. Inadequate energy intake compared 186 
with expenditure can affect performance and inadequate protein intake can result in 187 
reduced muscle mass and overall strength. These same considerations may be true 188 
for critically ill patients. 189 
Several factors require consideration regarding the role of nutrition in the 190 
generation of energy for exercise in critically ill patients. The first is adequate 191 
substrate delivery. It is well documented that critically ill patients do not receive 192 
prescribed amounts of nutrition regardless of route. Reasons for this include fasting 193 
for surgical and bedside procedures as well as high gastric residual volumes that are 194 
used as a crude bedside indication of enteral feeding intolerance. In the context of 195 
mitochondrial dysfunction described earlier, increasing substrate delivery may not 196 
improve ATP generation. Secondly, the contribution of endogenous glucose and 197 
amino acid production from the metabolic effects of stress on the overall energy 198 
needs of the patient during early critical illness is unknown. Lastly Insulin is a 199 
requirement for ATP generation. Insulin resistance during the acute phase of critical 200 
illness may therefore contribute to impaired ATP generation- the timing of nutrient 201 
provision for energy generation is likely a key factor.  202 
Delivery of nutrition does not necessarily equate to absorption, particularly in the 203 
early course of illness. Data have shown that there are alterations in both the rate 204 
and extent of nutrient absorption from the GI tract, even with post-pyloric feeding is 205 
utilized 29 30. This may limit the potential for nutrients to facilitate energy generation 206 
and with no quick bedside measure available to determine this elucidation of the 207 
relative contribution of poor absorption to subsequent functional disability remains 208 
unknown. Either way, delivery of nutrition should not be assumed to contribute to 209 
energy generation throughout the course of critical illness and physiological studies 210 
are required to understand this process. 211 
 212 
Can we use more efficient substrates? 213 
Current evidence suggests that physical rehabilitation does not lead to 214 
improvements in outcome in critically ill patients31 32.No data exists to  suggest 215 
current nutritional support practices lead to improvements in rehabilitation 216 
potential and physical and functional outcomes, as  unfortunately the nutritional 217 
status and intake of the patients has not been reported in such trials.  218 
 219 
Nutrition in the ICU is currently thought of in terms of carbohydrates, fat and 220 
protein. Recently, particular attention has been given to protein with updated 221 
guidelines recommending higher amounts in order to prevent loss of lean body 222 
mass33. Physiological studies have shown that protein intakes equivalent to 223 
1g/kg/day increase whole body protein turnover, thought to be as a result of 224 
increased protein synthesis. One small study has shown that increased delivery of 225 
amino acids to patients requiring PN increased handgrip strength at day 7 of ICU 226 
admission 34 However, no studies have investigated the effect of different protein 227 
doses directly on MPS. Indeed, studies have indicated that higher protein intakes are 228 
associated with increased rates of muscle wasting12 and others have shown that 229 
weakness was increased in patients receiving higher macronutrient doses from the 230 
addition of supplemental PN. For this reason, prospective studies investigating the 231 
effect of protein intake on MPS in critical illness are urgently required35.  232 
Exercise and nutrition go hand in hand and the nutrient or substrate requirement 233 
will be dependent on the duration and intensity of the exercise being performed. For 234 
example, protein intake during or immediately after resistance training has been 235 
found to increase MPS. However, continuous feeding, as in the case of the critically 236 
ill patient, make negate this physiological process due to the ‘muscle full effect’ 237 
whereby saturation of the muscle with amino acids does not lead to further 238 
increases in MPS. In this regard, intermittent feeding, coupled with resistance 239 
training, may improve protein turnover in critically ill patients29.  240 
 241 
For the reasons specified above, clinicians and researchers are seeking alternative 242 
substrates to improve mitochondrial function, MPS and subsequently the strength 243 
and rehabilitation potential of these patients. Critically ill patients have been likened 244 
to athletes with an intense training (critical care admission) and recovery phase. 245 
Ergogenic supplements and a varied substrate schedule used by athletes may prove 246 
efficacious in this patient cohort and provide an alternative or additional substrate 247 
to carbohydrate, fat and protein. Such supplements may include β-hydroxy-β-248 
methylbutyrate (HMB), Leucine, creatine, carnitine, nitrates and beta-alanine (Table 249 
1) 36. Although the exact mechanisms underlying the effect of these interventions on 250 
exercise performance remain unknown, studies in healthy and limited clinical 251 
populations are promising, albeit not consistent. 252 
 253 
Of the above-mentioned substrates, Leucine, HMB and creatine are perhaps the 254 
most widely studied36. Leucine itself has been widely studied for its effects on 255 
protein synthesis, mitochondrial function, glucose homeostasis, insulin action and 256 
subsequently recovery from exercise and other catabolic conditions36. The 257 
conversion of leucine to HMB has been considered a key pathway in protein 258 
homeostasis37.     HMB has been shown to attenuate the Ubiquitin Protesome 259 
Pathway (UPP) along with other catabolic pathways In addition, HMB has been 260 
shown to influence mitochondrial dynamics disuse (bed rest) and rehabilitation. 261 
Lastly, creatine has been shown to contribute to ATP synthesis during high-energy 262 
demands. Intramuscular creatine is phosphorylated to phosphocreatine which is 263 
followed by the phosphate from phosphocreatine plus free ADP being used for this 264 
process38.  265 
 266 
Along with these substrates, discussions around the benefit of inducing ketosis as an 267 
alternative fuel source for muscle are increasing. In early critical illness, traditional 268 
fuels may be bioenergetically inert, meaning that they are unable to contribute to 269 
ATP synthesis. Switching the fuel source to ketones may therefore be useful in this 270 
early phase to spare muscle and facilitate generation of ATP. 271 
 272 
Conclusions 273 
Patients may not be able to generate enough energy to undertake exercise in 274 
early critical illness due to mitochondrial dysfunction preventing ATP 275 
production. It is unlikely that one strategy alone will be successful in modifying 276 
this, but nutrition and exercise are most likely to have essential  synergistic roles 277 
to play. 278 
 279 
Key points: 280 
 281 
 The compromised bioenergetic status of the critically ill patient is unlikely to 282 
respond to increased substrate delivery 283 
 patients are likely to enter critical illness with varying abilities to oxidize 284 
substrate and produce ATP 285 
 The metabolic cost of resistance exercise in the critically ill patient is 286 
unknown 287 
 delivery of nutrition should not be assumed to contribute to energy 288 
generation 289 
 Research into alternative substrates in the critically ill is urgently needed if 290 
we are to prevent acute muscle wasting 291 
 292 
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 451 
 452 
  453 
Table 1: Potential substrates which may enhance muscle mass and exercise 454 
performance in the critically ill 455 
Substrate Current evidence  
-hydroxy--
methylbutyrate 
(HMB) 
 Increases MPS and decreases MPB 
 Increases lean body mass, aerobic and strength performance 
 Preserves muscle mass during bed rest, in the absence of 
exercise 
Leucine  Increases MPS via mTOR 
 May increase protein uptake into muscle 
Creatine  Phosphate from phosphocreatine plus free ADP used for ATP 
synthesis and therefore muscle contraction 
 Improves rate of recovery, thereby increasing MPS 
Carnitine  May delay fatigue during prolonged aerobic exercise  
 Enhances fat oxidation whilst sparing glycogen 
-alanine  Increases muscle carnosine which may enhance acute exercise 
performance 
Nitrates  Increase blood flow and subsequently nutrient delivery to the 
muscle leading to anabolism 
Ketones  Muscle sparing and provide an alternative fuel source 
 456 
MPS = Muscle Protein Synthesis; MPB = muscle protein breakdown; mTOR = 457 
mammalian target of rapamycin 458 
 459 
 460 
